X

Health & Biotech

Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.

Health: Zoono now has evidence its hand sanitiser can fight COVID-19; shares spike again

For weeks Zoono (ASX:ZNO) shares have surged as people demand its products wanting to protect themselves from the coronavirus, but maybe this…

Australia is a leader in cannabis biotechs – here are three stocks that could be poised for growth

As market watchers would know, cannabis stocks globally have had a wild ride over the last three years. The volatility…

Health: Jumbo adds MS, subtracts margins

Jumbo Interactive (ASX:JIN) has added MS (Multiple Sclerosis) Queensland to its cohort of charity lottery clients. MS Queensland has bought…

Zelira is worshipping at the FDA altar hoping it will smite enemies

Two years ago Zelira (ASX:ZLD) -- then Zelda -- was set to invade the German market, planning to storm the…

Here’s how to pick a successful drug out of the 99pc of failures

Getting a drug from hypothesis to market is almost impossible. Let’s say you have 1000 drug candidates nudging about petri…

Health: Wheeler dealer Probiotec spending money to make money

Last year, in July, pharmaceuticals company Probiotec (ASX:PBP) announced and completed a $23m acquisition in 31 days. In its half-year…

Explainer: How Osteopore’s technology can ‘regrow’ bones

Special Report: Osteopore’s bone regeneration technology is cutting edge and has far wider uses than many people realise.  A woman…

Dr Boreham’s Crucible: Cochlear can weather the coronavirus-induced China slump

If anyone in the medical sector hasn’t heard about the dangers of the coronavirus loud and clear by now, they…

Sales of MGCs new low-cost Mercury Pharma line are surging higher

Special Report: Purchase orders for Mercury Pharma have almost doubled in February as MGC continues to build traction in the…

Health: Noxopharm climbs 40pc after US FDA green lights trials of prostate drug

Prostate cancer fighting biotech Noxopharm (ASX:NOX) went for a run this morning on news the American regulator has approved its Investigational…

Biotech: It’s not a get-rich-quick scheme judging by these HY reports

We’re deep into half-year reporting season and a swarm of medical companies opened their books to investors overnight. Being biotechs,…

Health: Zoono is not one to waste a crisis as epidemics beef up revenue

Investors are continuing to pile into hand sanitiser play Zoono (ASX:ZNO) as if the China coronavirus epidemic still has months…